SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience Earns ‘A’ Rating in KCGS ESG Assessment for Fourth Consecutive Year

2025.11.19
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

2025.11.05
SK bioscience strengthens global vaccine partnerships to expand R&D pipeline competitiveness

2025.10.29
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

2025.10.15
SK bioscience Announces Start of RSV Preventive Antibody Administration for 2025-2026 Season

2025.10.02
SK bioscience Launches Influenza Vaccination Campaign Ahead of Flu Season “Get Vaccinated Before the Chuseok Holiday to Protect Your Family’s Health”

2025.09.29
SK bioscience Submits IND for Phase 3 Clinical Trial of 2-Dose Varicella Vaccine

2025.09.02
SK bioscience Successfully Concludes Nationwide Symposium Series on RSV Preventive Antibody ‘Beyfortus’

2025.08.29
SK Group Chairman Taewon Chey and Bill Gates to Strengthen Cooperation in Energy and Biotechnology

2025.08.22
SK bioscience Discusses Collaboration with the Gates Foundation to Advance Global Health

2025.08.21
SK bioscience Launches RSV Awareness Campaign at BeFe Baby Fair

2025.08.14
SK bioscience Releases 2025 ESG Report

2025.07.22